Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics

But which one is a better stock to buy right now? Join me in analyzing each, and we'll figure it out together. Long story short, the data suggest that its molecule could lead to significantly faster weight loss than the medicines currently being sold by Eli Lilly as well as Novo Nordisk, and with a comparable side effect profile. Study participants lost, on a placebo-adjusted basis, an average of 13.1% of their weight after just 13 weeks of treatment. The cash cushion is also likely sufficient for it to rec ...